Skip to content
← Myeloproliferative Neoplasms

HEALTH PROFESSIONAL · SOURCE READING

Treatment Options for PV

Source: Myeloproliferative Neoplasms Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 27, 2024 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Polycythemia Vera

Treatment options for PV include:

Phlebotomy.[7]

Source links and citations

Hydroxyurea.[9]

Source links and citations

Pegylated interferon alfa-2a.[10-12]

Source links and citations

Ropeginterferon alfa-2B.[13,14]

Source links and citations

Ruxolitinib.[15]

Source links and citations

Low-dose aspirin (≤100 mg) daily, unless contraindicated by major bleeding or gastric intolerance.[16]

Source links and citations

Continue within this section

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice